Industry litigation – Page 14
-
BusinessViral cancer therapy approved in the US
T-Vec is the first approved oncolytic virus, but its limited treatment scope means it is unlikely to become a blockbuster
-
BusinessPharma kickback claims lead to individual prosecutions
Warner Chilcott and Novartis face large fines for paying doctors to prescribe their drugs
-
Business
Nine dead in China plant blast
Explosion in Shandong province latest of several incidents in Chinese chemical plants
-
BusinessDuPont found liable for cancer case
US court orders firm to pay $1.6m in damages for disease linked to contaminated water supply
-
Business
EPA fines Mosaic Fertilizer over hazardous waste handling
US Environmental Protection Agency agrees settlement contract including $8m penalty and $800m in investments
-
BusinessControversial new trade deal finalised
The Trans-Pacific Partnership could raise the price of medicines, especially in developing nations
-
Business
Bristol-Myers Squibb fined for alleged Chinese bribes
US Securities and Exchange Commission accepts $14m settlement for charges covering the last five years
-
Business
Safety board fills in details of deadly DuPont leak
In interim investigation has outlined the events and safety failings leading to a methyl mercaptan release that killed four workers
-
BusinessBayer CropScience pays $5.6m to settle 2008 accident charges
Fine will fund environmental projects, fire department upgrades and wastewater treatment facilities
-
Business
Cancer Drugs Fund axes 23 treatments
The UK government has cut down the list of cancer therapies it will pay for through the Cancer Drugs Fund
-
BusinessUS regulator reprimands Cepheid for norovirus diagnosis tool quality
Diagnostics firm has 15 days to respond to violations laid out by regulator
-
Business
FDA takes action to remove biosimilars roadblock
The US Food and Drug Administration proposes system to name biosimilar drugs
-
BusinessFemale sexual desire drug approved
Concerns raised over efficacy, side effects and use of advocacy campaigning to influence regulatory decisions
-
BusinessIndian pharma under increased regulatory scrutiny
Import bans and tightened rules pose a significant challenge for companies
-
BusinessPorous pills could be largest industrial 3D printing use
US grants first-of-a-kind approval for Aprecia’s epilepsy tablets exploiting porous structure
-
BusinessGreek crisis puts pressure on pharmaceuticals
Public spending cuts and capital restrictions on banks have exacerbated drug supply problems in Greece
-
BusinessDeadly chemical blast at Chinese port
Explosion at warehouse in Tianjin kills at least 50 and injures hundreds, while ammonia leak sparks mass evacuations in Nanchong
-
BusinessUS regulator says DuPont’s safety programme ‘failed’
The US Occupational Safety and Health Administration has again proposed to fine DuPont after uncovering ‘repeated’ and ‘serious’ lapses in the company’s worker safety programme
-
Business
US import ban imposed on Indian pharma firm
Concerns over manufacturing processes at Emcure facility prompts Food and Drug Administration to block drug shipments
-
Business
Blast kills six at South Korean chemical plant
One further worker injured as tank explodes during welding work